Literature DB >> 7841543

Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line.

C Y Young1, P E Murtha, J Zhang.   

Abstract

12-O-tetradecanoyl phorbol ester (TPA) has profound cytotoxic effects on a human prostate cancer cell line, LNCaP. The TPA effect may be mediated via a protein kinase C (PKC) pathway, since staurosporine, a potent PKC inhibitor, could reverse the cell-killing effect. Our studies, based on cellular fragmentation, chromatin condensation, and nuclear fragmentation, suggest that the cell-killing effect is due to apoptosis. Moreover, we also examined expression of early growth response genes and androgen-induced genes in association with TPA-induced apoptosis. Northern blot analysis demonstrated that androgen induction of human glandular kallikrein-1 (hKLK2) mRNA was repressed by TPA in a concentration-dependent manner. A time course study showed that both hKLK2 and c-myc mRNAs were repressed by TPA as early as four hours. In contrast, the steady state mRNA levels for c-fos, c-jun, nerve growth factor induced gene A, and the orphan steroid receptor nur77 were rapidly induced within the first two hours of the treatment. Furthermore, transient co-transfection experiments demonstrated that c-fos and c-jun could repress androgen receptor-mediated gene induction. The above studies suggest that (1) the repression of androgen induction of gene expression by TPA-activated PKC is at least in part due to overexpression of c-jun and c-fos and (2) PKC may be a negative growth regulator in prostate cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7841543

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  13 in total

1.  Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.

Authors:  Li-Wu Guo; Lingqiu Gao; Julian Rothschild; Bing Su; Irwin H Gelman
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

2.  Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: preliminary studies on therapeutic efficacy and toxicity.

Authors:  Z T Han; X X Zhu; R Y Yang; J Z Sun; G F Tian; X J Liu; G S Cao; H L Newmark; A H Conney; R L Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action.

Authors:  N Kedei; A Telek; A M Michalowski; M B Kraft; W Li; Y B Poudel; A Rudra; M E Petersen; G E Keck; P M Blumberg
Journal:  Biochem Pharmacol       Date:  2012-11-09       Impact factor: 5.858

4.  Relative impact of 3- and 5-hydroxyl groups of cytosporone B on cancer cell viability.

Authors:  Zebin Xia; Xihua Cao; Elizabeth Rico-Bautista; Jinghua Yu; Liqun Chen; Jiebo Chen; Andrey Bobkov; Dieter A Wolf; Xiao-Kun Zhang; Marcia I Dawson
Journal:  Medchemcomm       Date:  2012-11-07       Impact factor: 3.597

5.  Lysophosphatidic acid promotes phorbol-ester-induced apoptosis in TF-1 cells by interfering with adhesion.

Authors:  J M Lai; C Y Lu; H F Yang-Yen; Z F Chang
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

6.  Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cells.

Authors:  Noemi Kedei; Emanuel Lubart; Nancy E Lewin; Andrea Telek; Langston Lim; Poonam Mannan; Susan H Garfield; Matthew B Kraft; Gary E Keck; Sofiya Kolusheva; Raz Jelinek; Peter M Blumberg
Journal:  Chembiochem       Date:  2011-05-03       Impact factor: 3.164

7.  Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; Edson J Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

8.  Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation.

Authors:  Petra Isabel Lorenzo; Fahri Saatcioglu
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

9.  Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells.

Authors:  Siva Kumar Kolluri; Nathalie Bruey-Sedano; Xihua Cao; Bingzhen Lin; Feng Lin; Young-Hoon Han; Marcia I Dawson; Xiao-kun Zhang
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer.

Authors:  P Cornford; J Evans; A Dodson; K Parsons; A Woolfenden; J Neoptolemos; C S Foster
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.